An experimental study of enhanced anticancer effect of intraperitoneal chemotherapy with high energy shock waves
高能冲击波腹腔化疗增强抗癌作用的实验研究
基本信息
- 批准号:06671277
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Antitumor activity of intraperitoneal cisplatin was examined in vitro. Erhlich ascites carcinoma cells were suspended in phyisiolosic saline which contained 5-50 mug/ml of cisplatin for 30 minutes, and intracellular uptake of cisplatin was measured. The accumulation of cisplatin taken up by Erhlich cells increased in proportion to the concentration of cisplatin. The cellular uptake of cisplatin in 10 mug/ml cisplatin solution increased chronologically. Then in vivo effects of intraperitoneal cisplatin and extracorporeal low-level ultrasonic waves were studied. A peritoneal carcinomatosis was induced in ddy mice by intraperitoneal injection of Erhlich cells. At 24 and 94 hours after cell injection, cisplatin solution (50 mug/ml) was administered at a dose of 5 mg/kg to ddy mice. Ultrasonic waves (28 kHz) were irradiated to mice for 3,5, or 10 minutes. When mices were treated at 24 hours after cell injection, the median survival days were 11.5,14.5,14.0,21.5 and 23 in the no-treatment, c … More isplatin alone, 3-minute ultrasonic waves, 5-minute ultrasonic waves and 10-minutes ultrasonic waves, respectively. The survival of intraperitoneal tumor-bearing ddy mice was greatly prolonged by intraperitoneal cisplatin and 5- or 10-minute ultrasonic waves as compared with those of the no-treatment or cisplatin aalone (P<0.01, Cox-Mantel test). When mices were treated at 96 hours after cell injection, the median survival days were 12.0 16.0,15.5,22.0 and 24.5 in the no-treatment, cisplatin alone, 3-minute ultrasonic waves, 5-minute ultrasonic waves and 10-minutes ultrasonic waves, respectively. The survival of intraperitoneal tumor-bearing ddy mice was greatly prologned by intraperitoneal cisplatin and 5- or 10-minute ultorasonic waves as compared with those of the no-treatment or cisplatin alone (P<0.01, Cox-Mantel test). These results indicate that the combination of intraperitoneal cisplatin and extracorporeal low-level ultrasonic waves may prevent and treat the peritoneal dissemination more effectively than the treatment of intraperitoneal cisplatin alone. Less
体外观察顺铂腹腔注射抗肿瘤活性。将Erhlich腹水癌细胞悬浮于含5-50杯/ml顺铂的生理盐水中30分钟,测定细胞内对顺铂的摄取。依氏细胞吸收的顺铂积累量与顺铂浓度成比例增加。10杯/毫升顺铂溶液中顺铂的细胞摄取按时间顺序增加。然后研究腹腔注射顺铂和体外低水平超声对小鼠体内的影响。通过腹腔注射Erhlich细胞诱导小鼠腹膜癌变。在细胞注射后24和94小时,以5 mg/kg的剂量给予顺铂溶液50 mg/ ml。超声波(28khz)照射小鼠3分钟、5分钟或10分钟。在细胞注射后24小时处理小鼠时,未处理组的中位生存天数分别为11.5、14.5、14.0、21.5和23天,分别为单药组、3分钟超声波组、5分钟超声波组和10分钟超声波组。腹腔注射顺铂和5、10分钟超声治疗组荷瘤小鼠的生存期明显延长(P<0.01, Cox-Mantel检验)。注射细胞后96 h,小鼠的中位生存天数分别为:不治疗组、单用顺铂组、超声波3分钟组、超声波5分钟组和超声波10分钟组的中位生存天数分别为12.0、16.0、15.5、22.0和24.5天。腹腔注射顺铂和5、10分钟超声治疗比不治疗和单独使用顺铂组的小鼠生存期明显延长(P<0.01, Cox-Mantel检验)。提示腹腔顺铂联合体外低水平超声治疗腹膜播散比单用顺铂治疗更有效。少
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
岡 淳夫: "低浸透圧シスプラチン腹腔内化学療法の制癌効果増強に関する実験的検討" 米子医学雑誌. 47. 81-93 (1996)
Atsuo Oka:“增强低渗透顺铂腹腔化疗抗癌效果的实验研究”米子医学杂志47. 81-93(1996)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
近藤 亮: "シスプラチン腹腔内化学療法の抗腫瘍性に及ぼす溶液浸透圧の影響" 米子医学雑誌. 45. 54-69 (1994)
Ryo Kondo:“溶液渗透压对腹腔内顺铂化疗抗肿瘤特性的影响”米子医学杂志 45. 54-69 (1994)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Oka, Atsuo: "An experimental study on enhanced anticancer effect of intraperitoneal hypotonic cisplatin chemotherapy" J Yonago Med Ass. 47. 81-93 (1996)
Oka, Atsuo:“腹腔内低渗顺铂化疗增强抗癌作用的实验研究”J Yonago Med Ass。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kondo, Akira: "Effect of fulid osmolarity on antitumor activity of intraperitoneal cisplatin chemotherapy" J Yonago Med Ass. 45. 54-69 (1994)
Kondo,Akira:“液体渗透压对腹腔内顺铂化疗抗肿瘤活性的影响”J Yonago Med Ass。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TSUJITANI Shunichi其他文献
TSUJITANI Shunichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TSUJITANI Shunichi', 18)}}的其他基金
Peritoneal dissemination of gastric cancer stem cells and immunotherapy overcoming immune escape
胃癌干细胞的腹膜传播和克服免疫逃逸的免疫治疗
- 批准号:
23591939 - 财政年份:2011
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of dendritic cell immunotherapy based on the chemokine expression profile of cancer cells
基于癌细胞趋化因子表达谱建立树突状细胞免疫疗法
- 批准号:
14370357 - 财政年份:2002
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of tumor-specific dendritic cell vaccine pulsed by tumor-derived heat shock protein or cell fusion with tumor cells
肿瘤源性热休克蛋白或与肿瘤细胞融合的肿瘤特异性树突状细胞疫苗的建立
- 批准号:
11470247 - 财政年份:1999
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effects of telomerase and intracellular signal transduction pathways on carcinogenesis and development of colorectal carcinoma
端粒酶及细胞内信号转导通路对结直肠癌发生发展的影响
- 批准号:
08671442 - 财政年份:1996
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
Entpd5在上皮性卵巢癌对Cisplatin继发耐药中的分子作用机制研究
- 批准号:81703078
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
构建基于TRAIL-exosome的siRNA和Cisplatin共载纳米系统及治疗耐药宫颈癌的研究
- 批准号:81671809
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
CUDC-101联合cisplatin对卵巢癌腹水细胞spheroid形成及转移机制的相关研究
- 批准号:81402127
- 批准年份:2014
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
XPC表达变异改变膀胱尿路上皮癌对Cisplatin敏感性的实验研究
- 批准号:30340057
- 批准年份:2003
- 资助金额:9.0 万元
- 项目类别:专项基金项目
相似海外基金
悪性軟部腫瘍術後hypotonic cisplatin treatmentの検証
恶性软组织肿瘤术后低渗顺铂治疗的验证
- 批准号:
24K19630 - 财政年份:2024
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Save Kidneys in Cisplatin Chemotherapy by blocking HDAC6
顺铂化疗中通过阻断 HDAC6 拯救肾脏
- 批准号:
10841270 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Role of MCT6 in mediating cisplatin-induced ototoxicity
MCT6 在介导顺铂诱导的耳毒性中的作用
- 批准号:
10646995 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Metabolic adaptation enables cisplatin resistance and inhibits tumor immunity
代谢适应使顺铂耐药并抑制肿瘤免疫
- 批准号:
10942977 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Active surveillance vs definitive local therapy for patients showing clinical complete response following neoadjuvant cisplatin-based chemotherapy
对基于顺铂的新辅助化疗后表现出临床完全缓解的患者进行主动监测与明确的局部治疗
- 批准号:
487681 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Operating Grants
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss in Head and Neck Cancer Patients
阿托伐他汀可减少头颈癌患者顺铂引起的听力损失
- 批准号:
10643500 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Unraveling the Role of MMP3 in the Cisplatin Resistance of Ovarian Cancer
揭示 MMP3 在卵巢癌顺铂耐药中的作用
- 批准号:
10412430 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
The role of PGC-1alpha in repeated low-dose cisplatin-induced kidney injury and the progression to chronic kidney disease
PGC-1α 在重复低剂量顺铂诱导的肾损伤和慢性肾病进展中的作用
- 批准号:
10640822 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Novel Pathways and Therapeutic Targets for Cisplatin-Associated Acute Kidney Injury
顺铂相关急性肾损伤的新途径和治疗靶点
- 批准号:
10868783 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:
Targeting nitrative stress for treatment of cisplatin ototoxicity
靶向硝化应激治疗顺铂耳毒性
- 批准号:
10587579 - 财政年份:2022
- 资助金额:
$ 1.41万 - 项目类别:














{{item.name}}会员




